AEG‐1 has been identified as a key contributor to hypoxia‐induced chemoresistance in HCC through modulation of the PI3K/AKT/HIF‐1α/MDR‐1 pathway. The gene discussed is AKT1; the disease is hepatocellular carcinoma.